Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases
重新思考和重新定义非传染性疾病药物和技术的可及性和可负担性，以及我们如何衡量这些疾病的可及性和可负担性。
期刊:Bmj Global Health
影响因子:6.1
doi:10.1136/bmjgh-2025-019355
Mettraux, Céline; Gilmoor, Andrew; Ewen, Margaret; Besançon, Stéphane; Giachino, Marina; Laurson-Doube, Joanna; Lepeska, Molly; Macé, Cécile; Perrin, Christophe; Tenorio Mucha, Janeth; Turkie, Rosalind; Beran, David
